Catalog
Help
Build your portfolio here
Enter the quantity next to the stocks you need — your portfolio will be created automatically.
Quick screener: filter by category and recommendation, review fundamentals, metrics and company profiles.
| Company | Category | Price | Δ% | Div% | Vol20 | EPS(TTM) | QoQ | EPS(SPR) | Style | Horizon | Pot. | Risk | Recommendation | Portfolio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kymera Therapeutics (KYMR) | Biotech | 119.46 | +3.49% | 0.0% | 2.3% | -3.25 | 89.1% | 13.0% | Growth | Long | 70 | 64 | Hold |
|
| Neurocrine Biosciences (NBIX) | Biotech | 156.54 | +0.90% | 0.0% | 1.3% | 7.05 | 17.7% | -15.8% | Growth | Medium | 54 | 69 | Hold |
|
| Ovid Therapeutics (OVID) | Biotech | 2.62 | -3.15% | 0.0% | 2.7% | -0.48 | -100.0% | 30.4% | Growth | Medium | 37 | 69 | Hold |
|
| Regeneron Pharmaceuticals (REGN) | Biotech | 797.58 | -1.25% | 0.5% | 1.7% | 41.88 | 19.0% | 40.6% | Growth | Long | 72 | 35 | Buy |
|
| Regenxbio (RGNX) | Biotech | 8.54 | -2.23% | 0.0% | 7.0% | -3.79 | 1589.6% | 446.2% | Growth | Short | 31 | 70 | Sell |
|
| Replimune Group (REPL) | Biotech | 13.43 | -7.05% | 0.0% | 3.3% | -3.15 | 0.0% | -3.7% | Growth | Long | 47 | 70 | Hold |
|
| Rhythm Pharmaceuticals (RYTM) | Biotech | 102.52 | +1.45% | 0.0% | 1.8% | -3.11 | 18.5% | 9.6% | Growth | Long | 43 | 70 | Sell |
|
| Roivant Sciences (ROIV) | Biotech | 40.60 | -2.89% | 0.0% | 0.0% | -0.38 | -42.8% | 0.0% | Growth | Long | 38 | 33 | Hold |
|
| Sarepta Therapeutics (SRPT) | Biotech | 20.32 | -7.74% | 0.0% | 4.4% | -1.44 | -45.1% | -123.0% | Growth | Medium | 40 | 71 | Sell |
|
| Scholar Rock (SRRK) | Biotech | 55.43 | +1.48% | 0.0% | 2.1% | -3.31 | 0.0% | 0.1% | Growth | Medium | 50 | 66 | Hold |
|
| Soleno Therapeutics (SLNO) | Biotech | 53.01 | 0.00% | 0.0% | 0.0% | 1.96 | 3.1% | -19.2% | Growth | Medium | 60 | 69 | Hold |
|
| SPDR S&P Biotech ETF (XBI) | Biotech | 156.87 | -1.57% | 0.4% | 2.0% | 0.00 | 0.0% | 0.0% | Growth | Medium | 60 | 70 | Hold |
|
| Terns Pharmaceuticals (TERN) (TERN) | Biotech | 52.95 | 0.00% | 0.0% | 0.0% | -1.03 | 0.0% | 13.3% | Growth | Medium | 44 | 70 | Sell |
|
| Ultragenyx Pharmaceutical (RARE) | Biotech | 14.30 | -0.06% | 0.0% | 9.8% | -5.84 | 57.4% | -23.7% | Growth | Medium | 14 | 90 | Sell |
|
| UniQure (QURE) | Biotech | 44.98 | -2.23% | 0.0% | 2.3% | -4.04 | 64.0% | -48.4% | Growth | Short | 49 | 70 | Sell |
|
| Vaxcyte (PCVX) | Biotech | 58.86 | -1.10% | 0.0% | 2.0% | -7.64 | 0.0% | 4.4% | Growth | Medium | 42 | 70 | Sell |
|
| Vera Therapeutics (VERA) | Biotech | 33.42 | -1.07% | 0.0% | 2.7% | -5.86 | 0.0% | 3.8% | Growth | Medium | 44 | 66 | Sell |
|
| Wave Life Sciences (WVE) (WVE) | Biotech | 4.67 | -2.81% | 0.0% | 2.5% | -1.09 | -94.1% | -13.4% | Growth | Medium | 30 | 80 | Sell |
|
| Xenon Pharmaceuticals (XENE) | Biotech | 58.65 | -0.55% | 0.0% | 2.0% | -4.74 | 0.0% | 2.6% | Growth | Medium | 40 | 70 | Sell |
|